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ABSTRACT f3-amyloid peptide (A,B) is the primary protein component of senile plaques in Alzheimer's disease patients.
Synthetic AP3 spontaneously assembles into amyloid fibrils and is neurotoxic to cortical cultures. Neurotoxicity has been
associated with the degree of peptide aggregation, yet the mechanism of assembly of A,B into amyloid fibrils is poorly
understood. In this work, Af3 was dissolved in several different solvents commonly used in neurotoxicity assays. In pure
dimethylsulfoxide (DMSO), A,B had no detectable (3-sheet content; in 0.1 % trifluoroacetate, the peptide contained one-third
(-sheet; and in 35% acetonitrile/0.1 % trifluoroacetate, A,B was two-thirds (-sheet, equivalent to the fibrillar peptide in
physiological buffer. Stock solutions of peptide were diluted into phosphate-buffered saline, and fibril growth was followed
by static and dynamic light scattering. The growth rate was substantially faster when the peptide was predissolved in 35%
acetonitrile/0.1 % trifluoroacetate than in 0.1 % trifluoroacetate, 10% DMSO, or 100% DMSO. Differences in growth rate were
attributed to changes in the secondary structure of the peptide in the stock solvent. These results suggest that formation of
an intermediate with a high (3-sheet content is a controlling step in A(3 self-assembly.
INTRODUCTION
/3-amyloid peptide (A,B) is the primary protein component
of senile plaques in Alzheimer's disease (AD) patients
(Wong et al., 1985). It is a 39- to 43-residue proteolytic
product of a membrane-associated precursor protein (Mas-
ters et al., 1985; Prelli et al., 1988; Kang et al., 1987). The
peptide self-assembles into amyloid fibers, which are char-
acterized by a cross-X3-pleated sheet structure, fibril diame-
ters of 5-10 nm, and birefringence upon staining with
Congo red. Amyloid fibers are deposited extracellularly in
the AD brain and are typically surrounded by degenerating
cells (Merz et al., 1981).
Synthetic AP3 readily forms amyloid fibrils in vitro
(Kirschner et al., 1987; Fraser et al., 1991a). A number of
studies have shown that addition of synthetic A,3 to cultured
cortical cells is associated with direct toxicity (see, for
example, Yankner et al., 1990; Busciglio et al., 1993) or
enhanced susceptibility to glutamate excitotoxicity (Koh et
al., 1990; Mattson et al., 1992). Recently, transgenic mice
carrying a mutant form of AP3 precursor protein have been
shown to produce AP3, develop amyloid plaques, and show
some signs of neuropathology similar to AD (Games et al.,
1995). The mechanism by which AP3 exerts toxic effects is
unknown, although numerous hypotheses have been put
forth. Differences in biological activity of AP3 solutions may
be related to differences in aggregation state (Pike et al.,
1991, 1993; Ueda et al., 1994), although there is some
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suggestion that aggregation state alone is not sufficient to
predict neurotoxicity (Busciglio et al., 1993).
Synthetic AP3 is generally difficult to dissolve directly
into physiological buffers. Researchers have overcome this
problem by preparing stock solutions of the peptide in a
variety of solvents before dilution into culture medium or in
vivo injection for assessment of biological activity. Com-
monly used solvents include dimethylsulfoxide (DMSO;
e.g., Mattson et al., 1993), aqueous acetonitrile with triflu-
oroacetic acid (ACN/TFA; e.g., Abe et al., 1994; Yankner et
al., 1990), and dilute aqueous TFA (e.g., Whitson et al.,
1994). There is some evidence that the solvent may alter the
biological activity of A13. Busciglio et al. (1992) measured
neuronal cell death after incubation of mixed cortical cul-
tures with synthetic A,B. Toxicity was greatest if the peptide
was first dissolved in aqueous ACN, intermediate if first
dissolved in pure water, and least if first dissolved in
DMSO. In contrast, Mattson et al. (1992) detected no direct
toxicity of A,B in cortical cultures but saw enhanced toxicity
to glutamate in the presence of the peptide. In this case,
stock solutions prepared with DMSO were 100-fold more
potent than those prepared with pure water.
In this study, the influence of solvent on self-assembly of
,3(1-39), a synthetic peptide corresponding to the first 39
residues of A13, was investigated. Stock solutions of P3(1-
39) in 100% DMSO, 10% DMSO, 0.1% TFA, or 35%
ACN/0.1% TFA were prepared. Secondary structure infor-
mation was obtained for the peptide in the stock solvents
using circular dichroism (CD) or Fourier transform infrared
(FTIR) spectroscopy. Stock solutions were diluted into
phosphate-buffered saline (PBS), and static and dynamic
light scattering data were collected and analyzed to deter-
mine fibril size and growth rate. The rate of fibril growth
was considerably faster when the stock solution was pre-
pared from ACN/TFA versus DMSO. The kinetics of fibril
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growth were analyzed in detail. This analysis sheds light on
the mechanism of self-assembly of A,B.
MATERIALS AND METHODS
A peptide homologous to the first 39 residues of A,B, ,B(1-39), was
synthesized, purified, and characterized as described previously (Shen et
al., 1994). The peptide was lyophilized from aqueous ACN/TFA solution
after high pressure liquid chromatography purification and stored at
-700C. Solvents used were 100% ACN (Baker, Phillipsburg, NJ); TFA,
free acid form (Sigma Chemical Co., St. Louis, MO); and 99.5% ACS
reagent grade DMSO (Sigma Chemical Co.).
Circular dichroism spectroscopy
,3(1-39) was dissolved in 35% ACN/0.1% TFA to a final concentration of
0.2 mg/ml. The solution was filtered through a 0.45-gm Millipore (Bed-
ford, MA) filter to remove dust and then degassed. CD spectra in the far
UV (190-240 nm) range were obtained with a modified Cary model 60
spectropolarimeter (On-line Instrument Systems, Bogart, GA) as described
previously (Shen et al., 1994).
Fourier transform infrared spectroscopy
Because of the strong absorbance of DMSO in the UV range, CD data
could not be obtained in this solvent. Instead, FTIR spectra were collected
on a Nicolet (Madison, WI) 740 FTIR instrument at a resolution of 2 cm- .
,3(1-39) was dissolved in pure DMSO at 5.0 mg/ml, incubated at room
temperature for 1 h, and placed in CaF2 windows with a pathlength of 150
,um. FTIR spectra were recorded and averaged from 64 scans and the
contribution from DMSO was subtracted.
Gel electrophoresis
,B(1-39) was radioiodinated by a modified Bolton-Hunter procedure (Good
and Murphy, 1995). Unlabeled peptide was dissolved at 10 mg/ml into pure
DMSO, 10% DMSO in water, 35% ACN/0.1% TFA, or 0.1% TFA and
doped with 10% by volume of a 0.004 mg/ml solution of radioiodinated
peptide in PBS. Aliquots were applied to a homogeneous 7.5% polyacryl-
amide gel (Pharmacia, Uppsala, Sweden) shortly after preparation. Gels
were electrophoresed with the Pharmacia pHastgel system. X-ray film
(Fuji) was exposed to unfixed gels at -70°C for 5 weeks, then developed
according to the manufacturer's instructions.
Static light scattering
Stock solutions were prepared by dissolving ,3(1-39) (10 mg/ml) into 35%
(v/v) ACN/0.1% (v/v) TFA, 0.1% (v/v) TFA, 10% (v/v) DMSO in water,
or 100% DMSO. Stock solutions were incubated for 1 h at 250C. PBS with
azide (PBSA; 0.01 M K2HPO4/KH2PO4, 0.14 M NaCl, 0.02% (w/v)
sodium azide) was double-filtered through a 0.22-pim filter (Millipore).
Samples were prepared by diluting peptide stock solutions into PBSA and
adjusting the pH to 7.4 with 0.5 N NaOH. All samples were at a final
peptide concentration of 0.5 mg/ml unless otherwise specified. Each sam-
ple was filtered through a 0.45-,um filter (Millipore) directly into the
light-scattering cuvette, which was temperature controlled to 25 + 0.1°C,
to initiate experiments. Static light scattering (SLS) data were collected as
described previously (Shen et al., 1993, 1994). SLS data are classically
analyzed by the equation:
Kc
-1='
=q= Mw,p X P(q)1 , (1)
where c is the peptide concentration, K = 41n2(dn/dc)2/NAAO4, dn/dc is
the refractive index increment, NA is Avogadro's number, Ao is the wave-
length of light in vacuo, q is the scattering vector (= 47n/A,sin(O/2)) at
scattering angle 0, (M),,app is the apparent weight-average molecular
weight, and P(q) is the particle scattering factor. The second virial coef-
ficient correction was ignored in Eq. 1, thus leading to the use of the
subscript app. For convenience, the subscript will be dropped for the
remainder of this report. For determination of dn/dc, solutions of peptide
were made at known concentrations and the refractive index of the solution
was measured using a Milton-Roy (Rochester, NY) Abbe-3L refractome-
ter. The refractive index increments of (3(1-39) in PBSA, 5% DMSO, and
10% DMSO were taken as 0.145 cm3/g, 0.180 cm3/g, and 0.180 cm3/g,
respectively. For all of the samples, dn/dc was assumed independent of
aggregation state.
The scattering factor P(q) is a function of particle shape. Two alterna-
tive models of particle shape, wormlike chain and wormlike star, were used
to fit SLS data. The wormlike chain model describes a linear chain with
total contour length Lc and Kuhn statistical segment length 'k (a measure of
the stiffness of the chain, equal to two times the persistence length). P(q)
for semiflexible wormlike chains is (Koyama, 1973)
2 L,
P(q) =2 J(LC ) X p(t, lk, q)dt,
0
(2)
where the function 4(t.lk,q) has been described elsewhere (Koyama, 1973;
Shen et al., 1994). The continuous wormlike star model assumes that any
two arms of the star is a wormlike chain, that all arms are of identical
length, and that the flexibility at the branch point is the same as that of the
rest of the chain. P(q) for the continuous wormlike star model is a function
of lk, the contour length of one arm Lc,a and the number of branches f
(Huber and Burchard, 1989):
1 (2 f LaPq) 2n t2(2 -f) (Lc,a -x,odx
+ (f j1) (2LCa-x)4dx} (3)
Scattered intensity data were plotted as q2R,(q)/Kc (= q2(M)wP(q))
versus q (Kratky plot). (M)W, 'k LC (or L a), and, where appropriate,fwere
determined by nonlinear regression using the parameter estimation soft-
ware program GREG (Stewart and Sorensen, 1981), with numerical inte-
gration to evaluate Eq. 2 or 3. To reduce covariances to acceptable levels,
fitting was done by reparameterization to the parameter set ((M)w, LC, Lclk)
for Eq. 2 or ((M)w, Lcd,a Lcalk, andfL,a5) for Eq. 3. (M)w was independently
determined by extrapolation of Kc/RS versus q2 to q2 = 0 using Eq. 1 and
in all cases agreed to that determined by regression to the multiple param-
eter set within experimental error.
The apparent fibril diameter was calculated assuming a solid cylindrical
geometry using
d 4a( V()Vh)05dap = - NAL (4)
where the estimated hydrated specific volume Vh of 3(1-39) is 1.11 cm3/g
(Kuntz and Kauzmann, 1974; Cohn and Edsall, 1943). For particles fit to
the wormlike star model, L, = JLca in Eq. 4.
Dynamic light scattering
Dynamic light scattering (DLS) experiments were performed as described
previously (Shen et al., 1994) using the same samples as used for SLS
experiments. Data were collected at 300, 450, 700, 900, and 1200 scattering
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angles beginning 1 h after sample preparation. Autocorrelation data were
fit to a third-order cumulants expression (Koppel, 1972):
1 1
InIg(l)(T)i = -(F)T + 2! A 3!2 L3T3 + (5)
to obtain the initial decay rate (IF), where(F1 can be considered a
relaxation time corresponding to the time scale for motion of particles in
solution. (F)lq2 was extrapolated to q = 0 to yield the apparent z-average
mutual diffusion coefficient D2,m. Alternatively, autocorrelation data were
fit to a biexponential form:
g(1)(T) = Af exp(-rfT) + As exp(-rsT) (6)
where rf = Dfq2 and rF = Dsq2 correspond to fast and slow diffusive
modes with amplitude Af and As and diffusivities Df and Ds, respectively.
The theoretical translational diffusion coefficient DY-F for wormlike
chains was calculated from Lc and Ik using the equations of Yamakawa and
Fujii (1973). For wormlike stars, DY-F was calculated from the same
equations, assuming that Lc = JLc,a (Burchard et al., 1980).
Thioflavin T fluorescence spectroscopy
Thioflavin T (ThT; Sigma Chemical Co.) was dissolved at 100 ,uM in
PBSA. The peptide was dissolved at 10 mg/ml in each of the stock
solvents, incubated for 1 h at 25°C, then diluted 20-fold into PBSA. At
various time intervals after dilution, 40 ,ul of peptide solution and 40 ,ul of
ThT stock solution were mixed with 920 ,Al of PBSA. The mixture was
briefly vortexed before obtaining fluorescence measurements. Fluores-
cence emission spectra were taken from 460 nm to 500 nm at an excitation
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wavelength of 450 nm with a Model M-3 Alphascan (Photon Technology
International, South Brunswick, NJ) spectrofluorimeter and a 1 X 0.4 cm2
cuvette at a temperature of 25 ± 0.1°C. Triplicate measurements were
performed for each sample. A maximum at 482 nm was indicative of the
presence of amyloid (LeVine, 1993). Fluorescence intensity for diluted
ThT in the absence of peptide was determined and subtracted from sample
intensities.
RESULTS
Characterization of peptide in stock solutions
CD spectra for ,B(1-39) in 0.1% TFA and in 0.01 M phos-
phate, pH 7.4, were reported previously (Shen et al., 1994).
Quantitative analysis of the CD spectra indicated that the
peptide retained some conformation in 0.1% TFA, with
approximately one-fourth (3-turn, one-third (3-sheet, and the
remainder disordered. In 35% ACN/0.1% TFA, CD spectra
of the peptide was similar to the peptide in phosphate buffer
(Fig. 1 A). Fitting of the spectra yielded an estimate of the
peptide conformation as approximately two-thirds 13-sheet
and one-third disordered in either ACN/TFA or phosphate
buffer. FTIR spectra for the peptide in 100% DMSO had no
detectable peak at 1640-1620 cm-', indicating that the
peptide has no ,3-sheet content in this solvent (Fig. 1 B).
FTIR cannot be used to discriminate readily between a-he-
lical and random coil conformations; NMR studies indi-
cated that the peptide (3(1-28) is partially a-helical and
partially random coil in DMSO (Sorimachi and Craik,
1994).
Stock solutions of (3(1-39) migrated with the dye front
when subjected to native gel electrophoresis on a 7.5%
polyacrylamide gel (data not shown). Light scattering from
samples of 0.5 mg/ml (3(1-39) in 100% DMSO, 0.1% TFA,
or ACN/TFA was too weak to be detectable above noise.
(Analysis of samples at the stock concentrations, 10 mg/ml,
was not done because of the prohibitively large quantity of
peptide required.) Scattering was sufficiently strong to be
measured for 0.5 mg/ml (3(1-39) in 10% DMSO. Intensity
data for this solution were plotted as q2R5lKc (=
q2(M)wP(q)) versus q (Fig. 2) and fit using P(q) of a
E
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FIGURE 1 Secondary structure of 13(1-39) as a function of solvent. (A) CD
spectra of (3(1-39) at 0.2 mg/ml in 35% ACN/0.1% TFA (A), 0.1% TFA (0),
or phosphate buffer (L]). (B) FTIR spectra of (3(1-39) at 5 mg/ml in 100%
DMSO. The broad peak near 1665 cm- 1 is a result of residual TFA from the
lyophilized peptide and a-helical or random coil conformation.
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FIGURE 2 Kratky plot of 0.5 mg/ml ,3(1-39) in 10% DMSO. The solid
line represents the nonlinear least-squares fit of the data using the wormlike
chain model (Eq. 2).
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wormlike chain (Eq. 2). Particles had an average molecular
mass (M), of 1.2 + 0.1 X 106, an average contour length Lc
of 360 ± 30 nm, and an average Kuhn statistical length lk
of 230 ± 10 nm. (M)W and Dz,m (2.3 ± 0.3 X 10-8 cm2/sec)
did not change significantly over a 48-h measurement pe-
riod. The apparent fibril diameter was calculated from Eq. 4
as 2.8 nm. These fibrillar aggregates were amyloid as evi-
denced by positive staining with Congo red and ThT (data
not shown). Electron microscopic examination confirmed
the presence of fibrils with some curvature in this solvent
mixture (data not shown).
Effect of stock solvent on aggregation rate
The kinetics of aggregation were determined by DLS. Data
collection was stopped when signal quality decreased,
which was concomitant with the appearance of visible pre-
cipitates. D41, which is proportional to the effective hydro-
dynamic radius from the Stokes-Einstein equation, was cal-
culated from a cumulants fit to the data (Eq. 5) and plotted
in Fig. 3 as a function of time and initial stock solvent. Dz 1
for the sample made from the ACN/ITFA stock solution
increased rapidly. In sharp contrast, Dj 1 for samples pre-
pared by dilution of TFA or 10% DMSO stocks increased at
intermediate rates, and Dzj1 for the sample prepared from
dilution of 100% DMSO stock solution increased slowly.
Precipitates were observed both visually and by a decay in
signal quality approximately 12 h or 4, 5, or 9 days after
dilution from ACN/TFA, 10% DMSO, TFA, or 100%
DMSO, respectively, into PBSA.
ThT fluorescence as a function of stock solvent was
determined (Fig. 4). Initially, the sample prepared from
DMSO stock solvent had a lower ThT fluorescence inten-
sity compared with 0.1% TFA or 10% DMSO stock sol-
vents, paralleling results of the DLS measurements. The rate
of increase of fluorescence intensity was slow for the first
3-4 days, then increased sharply after 4-8 days. After 8
days, fluorescence intensity for all three samples was sim-
ilar. The jump in fluorescence intensity correlated approx-
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FIGURE 3 Aggregation rate as a function of initial solvent. Inverse
apparent mutual diffusion coefficient Dz 1 for ,3(1-39) at 0.5 mg/ml in
PBSA, with stock solution prepared at 10 mg/ml peptide in 35% ACN/
0.1% TFA (A), 10% DMSO (0), 0.1% TFA (O), or 100% DMSO (A).
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FIGURE 4 ThT fluorescence intensity as a function of initial solvent.
Fluorescence intensity was measured at 482 nm with excitation at 450 nm
for 0.5 mg/ml in PBSA, with stock solution prepared at 10 mg/ml peptide
in 10% DMSO (0), 0.1% TFA (@), or 100% DMSO (A).
imately with the appearance of visible precipitates in light
scattering measurements.
Solvent effects on fibril dimensions
For samples prepared in the stock solvents 100% DMSO,
0.1% TFA, 10% DMSO, or ACN/TFA, SLS data were
collected 12 h after dilution of the peptide stock solution
into PBSA. For the sample made from ACN/TFA stock
solution, large fluctuations in the average scattered intensity
resulting from incipient precipitation precluded collection
of SLS data.
Intensity data were plotted as q2R5/Kc (= q2(M)wP(q))
versus q for samples prepared from stock solutions of 100%
DMSO, 0.1% TFA, or 10% DMSO diluted 20-fold into
PBSA (Fig. 5). Comparison of the shape of each curve
indicates that particle morphologies differ among the three
samples. The shape of the curve for the sample prepared
from 100% DMSO stock solution (Fig. 5 A) is typical for a
linear, nonbranching, semiflexible chain (Schmidt et al.,
1985). In contrast, the appearance of a bump at intermediate
values of q indicates that fibrils of ,3(1-39) may contain
some branched structures (Burchard, 1977; Burchard and
Muller, 1980) when prepared from stock solutions of 0.1%
TFA (Fig. 5 B) or 10% DMSO (Fig. 5 C).
To fit the particle structure factor P(q) to the data, as-
sumptions regarding particle morphologies were needed.
Based on electron micrographs (not shown), the particles
were assumed to be semiflexible fibrils and therefore could
be modeled as wormlike chains using Eq. 2. Where this
particle morphology inadequately represented the experi-
mental particle structure data, the wormlike star model
(Huber and Burchard, 1989) was used. In Fig. 5, nonlinear
regression fits to the wormlike chain and/or the wormlike
star models are shown. For the sample prepared from 100%
DMSO, the simpler wormlike chain model accurately rep-
resented the angular dependence of the scattered intensity.
For the sample prepared from 0.1% TFA, although a fairly
good fit to the wormlike chain model was obtained, the
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FIGURE 5 Representative Kratky plots for SLS data taken 12 h after
sample dilution. All samples were prepared by 20-fold dilution of 10
mg/ml stock into PBSA. (A) 100% DMSO stock solution. The solid line
represents the fit to the data using the wormlike chain model (Eq. 2). (B)
0.1% TFA stock solution. The solid line represents the fit to the data using
the wormlike star model (Eq. 3) and the dotted line represents the fit to the
data using the wormlike chain model. (C) 10% DMSO stock solution. The
solid line represents the fit to the data using the wormlike star model.
additional parameter in the wormlike star model produced a
statistically improved fit. For the sample prepared from 10%
DMSO, convergence to the wormlike chain model was not
obtained, but fitting to the wormlike star model was good.
Results from fitting the data in Fig. 5 are summarized in
Table 1. (M)w, Lc,a, and LC increased in the order 100%
DMSO < 0.1% TFA < 10% DMSO. The degree of branch-
ing also depended on initial conditions; the sample made
from 100% DMSO was unbranched, whereas samples made
from 10% DMSO and 0.1% TFA showed a low degree of
branching. Fibril stiffness in samples made from 10%
DMSO and 0.1% TFA was identical. lk could not be deter-
mined by regression for the sample made from 100%
DMSO, indicating that the Kuhn length of these fibrils
approaches the contour length of the fibril. The apparent
fibril diameter dapp was calculated from (M)W/LC, where Lc
= fLc,a, using Eq 4. The data are included in Table 1. dapp
increases for samples prepared from different stock solu-
tions in the order 100% DMSO < 0.1% TFA < 10%
DMSO.
TABLE 1 Effect of stock solvent on aggregate size
and morphology
Stock solvent
100%
DMSO 0.1% TFA 10% DMSO
(M), (106 Da) 1.14 + 0.07 12.1 ± 0.3 25 ± 1
Lc,a (nm) 230 + 20* 290 ± 40 280 ± 40
Ik (nm) NDt 150 ± 10 140 ± 20
f NA§ 3.2 ± 0.4 3.8 ± 0.4
L. (=Jc,a) (nm) 230 ± 20 900 ± 200 1100 ± 300
dapp (nm) 3.4 + 0.1 5.6 ± 0.2 7.5 ± 0.3
(3(1-39) was dissolved at 10 mg/ml in the stock solvent, then diluted into
PBSA to 0.5 mg/ml. Results are from SLS data taken 12 h after sample
dilution.
* Lc, not Lc,a.
t Not determined.
§ Not applicable in wormlike chain model.
DLS data taken 12 h after sample dilution were analyzed
using Eq. 6. The existence of well separated fast and slow
diffusive modes was apparent at all angles for the ACN/
TFA, 10% DMSO, and TFA samples. No slow mode was
reliably detected for the DMSO sample. Results from fitting
the DLS data are summarized in Table 2 and compared with
theoretical calculations for the translational diffusion coef-
ficient DY-F. These calculations show reasonable agreement
between the measured Df and the theoretical DY-F for indi-
vidual fibrils. Thus, Df can be ascribed to diffusion of
individual fibrils. Interpretation of slow diffusive modes is
still controversial. Given the strong dependence of DS on
scattering angle and time for our samples, DS may be
attributed to diffusion of large aggregates of fibrils (Seery et
al., 1992; Drogemeier et al., 1994).
By using DLS data for this sample, Df and DS for the
sample diluted from ACN/TFA were determined. Assuming
lk = 150 nm and d = 5 nm, and by using the Yamakawa-
Fujii relationships, L, for this sample was estimated from
Df. DLS data taken 1 h after sample dilution for all four
TABLE 2 Effect of stock solvent on hydrodynamic
properties of fibril aggregates
Stock solvent
100% 0.1% 10%
DMSO TFA DMSO ACN/TFA
I h
Df (10-8 cm2/s) 13 1 7 ± 2 4 ± 1 2.4 ± 0.4
DS (10-8 Cm2/S) 0.7 + 0.4 1.7 ± 0.2 1.1 ± 0.2 0.81 ± 0.01
L,* (nm) 150 300 700 1500
12 h
Df (10-8 cm2/s) 5.6 0.7 4 1 3 1 0.33 ± 0.04
DS (10-8 Cm2/S) 0.0 + 0.4 1.0 + 0.2 0.99 + 0.07 0.03 ± 0.01
DY-F (10-8 cm2/s) 8.7 3.3 3.1
LC* (nm) 450 700 1100 >104
,B(1-39) was dissolved at 10 mg/ml in the stock solvent, then diluted into
PBSA to 0.5 mg/ml. Results are from DLS data taken 1 h and 12 h after
sample dilution.
* Estimated from Df using the Yamakawa-Fujii (1973) equations and
assuming 'k 150 nm and d = 5 nm.
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samples were similarly analyzed and used to estimate L,.
Results from these calculations are included in Table 2.
These results show that, at 1 h after sample dilution, long
fibrils have already formed and, at both 1 h and 12 h after
sample dilution, fibril length increases in the order 100%
DMSO < 0.1% TFA < 10% DMSO < ACN/TFA.
SLS data were collected for samples over time and ana-
lyzed for fibril characteristics (Figs. 6 and 7). (M), and Lc
both increased with time for all three samples. There was no
evidence of branching at any time in the 100% DMSO
sample. In contrast, samples prepared from 10% DMSO and
0.1% TFA both showed a low degree of branching, with the
degree of branching increasing slowly with time. For all
three samples, lk remained constant or decreased slightly
with time, within experimental error. The Kuhn length
decreased with increasing Lc, suggesting that fibril stiffness
may be a weak inverse function of contour length.
For the sample prepared from 100% DMSO, the increase
in the average molecular weight (M)w correlated with an
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FIGURE 6 Fibril size as a function of time and initial solvent. All
samples were prepared by 20-fold dilution of stock solutions at 10 mg/ml
into PBSA. Kratky plots were fit to the wormlike chain model (100%
DMSO stock solution, A) or the wormlike star model (0.1% TFA, *; and
10% DMSO stock solutions, 0). (A) Weight-average molecular weight,
(M),. (B) Contour length of an arm, Lc a. For the sample prepared from
100% DMSO, Lc,a was calculated from the fitted value of L, by dividing by
2, the number of "branches" in an unbranched chain. (C) Total contour
length, Lc. For samples prepared from 0.1% TFA or 10% DMSO, Lc =
fLc,a
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FIGURE 7 Fibril morphology as a function of time and solvent. See Fig.
6 legend for details. (A) Kuhn statistical segment length Ik. (B) Number of
branchesf(f= 2 for an unbranched chain). (C) The apparent fibril diameter
dapp' calculated using Eq. 4.
increase in the contour length Lc of the fibril. For the
samples prepared from 0.1% TFA or 10% DMSO stock
solutions, the increase in (M), was accompanied by both an
increase in degree of branching f and an increase in the
contour length Lc,a. The apparent diameter dapp, calculated
by using Eq. 4, was constant or increased only very slightly
with time for all three samples.
We attempted to determine the polydispersity of the
samples by incorporating the Schulz-Zimm distribution into
the particle scattering factor (Gamini and Mandel, 1994).
Fitting of the light scattering data to this model resulted in
determination that the fibril size distribution was essentially
monodisperse.
Effect of peptide concentration on fibril growth
from 0.1% TFA
Samples were prepared by dissolving 10 mg/ml 13(1-39) in
0.1% TFA, incubating for 1 h, and then diluting into PBSA
to a final concentration of 0.1-1 mg/ml. SLS data were
collected for samples at final peptide concentrations of 0.3,
0.5, and 1.0 mg/ml and fit with the wormlike star model
(Eq. 3). Results from data taken 12 h after dilution are
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summarized in Table 3. (M)w, 'k, and dapp did not change
significantly with concentration. Lc, Lca, and f increased
with decreasing concentration, but the differences were not
statistically significant. Results from analysis of DLS data
taken 12 h after sample dilution are included in Table 3.
DY-F was calculated as described previously and compared
with Df. These data show a decrease in fibril diffusivity
(increase in fibril length) with decreasing concentration. At
lower peptide concentrations (0.1-0.2 mg/ml), signal inten-
sity was sufficient to collect DLS but not SLS data. Df and
DS were determined from DLS data for five concentrations
(0.1-1 mg/ml) taken 1 h after sample dilution (Table 4). Lc
was calculated from Df as described previously. Again,
there is an indication that the fibril length is greater (Df is
smaller) at the lower concentrations.
Variability in samples prepared from DMSO
stock solution
Light scattering data for samples prepared from stock solu-
tions of 0.1% TFA or ACN/TFA were reproducible (data
not shown). In contrast, samples prepared from 100%
DMSO stock solution and diluted to a final peptide concen-
tration of 0.5 mg/ml exhibited two types of behavior. Re-
sults from cumulants analysis of DLS data for four inde-
pendent runs are shown in Fig. 8. The increase in D-A of the
peptide solution prepared from this solvent appeared to
follow one of two pathways: slow growth, as shown previ-
ously in Fig. 3, or rapid growth, intermediate between that
for 0.1% TFA and ACN/TFA stock solutions. For the sam-
ples that grew rapidly, visible precipitates after -12 h were
observed. For one rapidly growing sample, SLS data were
collected at 12 h and analyzed. (M)w was 1.1 + 0.1 X
or approximately 10-fold greater than that obtained for two
other samples prepared from DMSO stock solution and
analyzed. These fibrils were extremely long (2200 + 300
nm) but with no evidence of branching. dapp was 3.4 nm,
similar to the slowly growing sample.
Results from cumulants analysis of DLS data for two
samples diluted from 100% DMSO to a final peptide con-
centration of 1 mg/ml are included in Fig. 8 for comparison.
TABLE 3 Effect of concentration on aggregate size
and morphology
Concentration (mg/ml)
0.3 0.5 1.0
(M)W (10" Da) 15.6 1.1 12.1 + 0.3 12.3 + 0.4
L.,a (nm) 310 70 290 + 40 230 + 50
lk (nm) 160 + 30 15t) + 10 180( + 20
Jf 3.5 + 0.7 3.2 + 0.4 3.0 + 0.6
L, ( =i.La) (nm) 1100 500 9(( + 200 700 + 30(0
dt,pp (nm) 5.8 0.4 5.6 + 0.2 6.5 + 0.4
Df (10 c'Cm2/s) 2.3 + 0.2 4 + 1 4.4 0.7
D, (10-x cm2/s) 0.57 + 0.05 1.0 + 0.2 1.1 0.1
DY-F (10-8 CM2/S) 2.8 3.3 3.7
3(1-39) was dissolved at 10 mg/ml in 0.1% TFA, then diluted into PBSA.
Analysis of SLS data at 12 h after sample dilution gave
(M)w=-9 0.7 106, Lc 720 40 nm, k 170+ 10
nm, and d.1p =5.4 + 0.2 nm, with no branching.
Effect of residual solvent
In preparing the sample from stock solutions, some residual
solvent is present in the final sample. To determine whether
the residual solvent influenced peptide assembly, samples
were prepared from 0.1% TFA stock solution, diluted into
PBSA containing 5% (v/v; 1.2 mol%) DMSO or 1.75%
(v/v; 0.95 mol%) ACN, and analyzed by dynamic and static
light scattering. Df, Ds, and (M)w were essentially indistin-
guishable from the peptide prepared from 0.1% TFA stock
solution and diluted into PBSA (Fig. 9). Adjusting the
concentration of TFA in the final solution in the range
0.001-0.005% had no effect on DLS results (data not
shown). These data show that the residual solvent does not
have a significant effect on fibril growth.
DISCUSSION
Neurotoxicity of AP3 has been demonstrated in multiple
studies (e.g., Yankner et al., 1990; Loo et al., 1993; Bus-
ciglio et al., 1993; Games et al., 1995). Increasing degrees
of peptide aggregation may correlate with increasing levels
of neurotoxicity (Pike et al., 1991, 1993; Ueda et al., 1994).
In most studies of AO3 neurotoxicity, however, aggregation
has not been measured at all or has been loosely defined as
material that precipitates or that sediments with centrifuga-
tion. To interpret neurotoxicity assays, to evaluate the role
of aggregation in toxicity, and to develop therapeutic ap-
proaches for intervention in AP3-mediated neurotoxicity, a
more thorough knowledge of the mechanism of self-assem-
bly of AP3 is needed.
The purpose of this investigation was to determine the
effect of predissolution of A,B in various stock solvents on
Af3 self-assembly. Predissolution in stock solvents is com-
monly practiced to overcome the limited solubility of A,B in
physiological buffers used in neurotoxicity assays. Our re-
sults clearly demonstrate that the rate of increase in fibril
length or (M)w in PBS is a strong function of the stock
solvent and is correlated to the secondary structure of the
peptide in the stock solvent. Consideration of the role of
solvent in determining the aggregation rate and extent yields
insight into the pathway and rate-limiting steps of A,B
self-assembly.
f3(1-39) contains the same degree of ,B-sheet in ACN/
TFA as in phosphate buffer at neutral pH. In contrast, the
peptide has no f3-sheet content when dissolved in 100%
DMSO. ACN and DMSO are both polar aprotic solvents
and are both capable of acting as hydrogen bond acceptors.
However, their properties differ in significant ways. In
particular, ACN forms hydrogen bonds with water that are
weaker than water-water hydrogen bonds (Marcus and Mi-
gron, 1991; Kovacs and Laaksonen, 1991), whereas DMSOResults are from data taken 12 h after sample dilution.
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TABLE 4 Effect of concentration on hydrodynamic properties of fibrils
Concentration (mg/ml)
0.1 0.2 0.3 0.5 1.0
Df (10-8cm21s) 5 ± 1 5.4 ± 0.7 8 ± 2 7 ± 2 7 ± 1
Ds (o-8 Cm2/S) 1.3 t 0.3 1.0 + 0.1 1.4 ± 0.3 1.7 t 0.2 1.3 t 0.1
Lc* (nm) 500 450 250 300 300
,B(1-39) was dissolved at 10 mg/ml in 0.1% TFA, then diluted into PBSA. Results are from DLS data taken 1 h after sample dilution.
* Estimated from Df using the Yamakawa-Fujii (1973) equations and assuming 1k = 150 nm and d = 5 nm.
forms long lasting hydrogen bonds with water that are
stronger than water-water hydrogen bonds (Migron and
Marcus, 1991; Luzar and Chandler, 1993). ACN in aqueous
solutions disrupts protein tertiary structure by solubilizing
hydrophobic regions, as a result of the decrease in solvent
polarity (Mant and Hodges, 1992). Addition of ACN to
water also lowers the dielectric constant, so that electrostatic
repulsive interactions present at low pH are enhanced. How-
ever, ACN can actually increase the stability of secondary
structures, probably because of a change in the relative
strength of the peptide-peptide hydrogen bond vis-a-vis the
peptide-water hydrogen bond (Mant and Hodges, 1992). In
sharp contrast, DMSO competes effectively with peptide
carbonyl groups for hydrogen bonding to peptide amine
groups, thus destabilizing secondary structures. Pure DMSO
can lead to a complete loss of secondary structure in pro-
teins with high /3-sheet content (Jackson and Mantsch,
1991). Thus, the two organic solvents have opposing effects
on AP3 secondary structure. In pure DMSO, A/3 appears to
be monomeric (Snyder et al., 1994) and lacks any /3-sheet
character (this work); in ACN/TFA, A,B is present as a
multimer (Snyder et al., 1994) with considerable ,B-sheet
content (this work), but extensive self-assembly is inhibited,
probably primarily by inhibition of hydrophobically driven
association.
In dilute TFA (pH -2), protonation of basic side chains
results in the loss of any ion pairing interactions that may
stabilize fibrils (Kirschner et al., 1987; Fraser et al., 1991b,
1992, 1994) and leads to electrostatic repulsion, particularly
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FIGURE 8 Variability in aggregation rate for samples prepared from
100% DMSO stock solutions. Four representative runs are shown in which
the final peptide concentration was 0.5 mg/ml (A, A, *, 0). Two runs are
shown in which the final peptide concentration was 1 mg/ml (M or C).
between N-terminal segments of this amphiphilic peptide.
These forces result in the retention of some /3-turn and
/3-sheet structure, although the structure is clearly different
from that of the peptide at neutral pH. CD measurements do
not distinguish between mixtures of conformers or mixed
conformations in a single peptide molecule. We have pre-
viously reported that /3(1-39) in 0.1% TFA elutes as a single
peak on a size exclusion column with a molecular weight
intermediate between monomer and dimer (Shen et al.,
1994). Thus, in this solvent, /3(1-39) may exist as a mono-
mer or dimer with partial /3-sheet character or as a mixture
of disordered monomer and /3-sheet dimer.
The secondary structure of A/3 in 10% DMSO was not
directly measured. However, from light scattering and ThT
fluorescence assays, it is clear that this solvent mixture does
not prevent amyloid fibril formation. This low concentra-
tion of DMSO is unlikely to be sufficient to disrupt second-
ary structure (Jackson and Mantsch, 1991). Unlike the other
samples diluted into PBSA, fibrils in 10% DMSO reach
what appears to be a stable size. This could be a result of the
combined effect of DMSO-mediated interference with hy-
drogen bonding in extended /-sheets, reduced importance
of hydrophobic interactions because of the absence of salt,
and pH effects (as the solution was not buffered).
Upon dilution into PBSA, all peptide solutions aggre-
gated into amyloid fibrils. Increases in size, as quantified by
Dz, (M), or Lc, continued unabated for hours to days,
until the onset of precipitation. The rate of increase in size
depended strongly on the stock solvent. The amyloid nature
of the fibrils was indicated by ThT fluorescence. Fluores-
cence intensity for the peptide sample prepared from 100%
DMSO was lower than for samples prepared from 10%
DMSO or 0.1% TFA for the first several days. Taken
together, these data indicate that the degree of /3-sheet
structure of the peptide in the initial solvent, the ThT
fluorescence intensity, and the fibril growth rate are all
generally lowest for solutions prepared from 100% DMSO,
intermediate for solutions prepared from 0.1% TFA or 10%
DMSO, and greatest for solutions prepared from ACN/TFA.
The correlation between /3-sheet content in the stock
solvent and fibril growth rate after dilution suggests that the
structure of the peptide in the stock solvent is "remem-
bered" upon dilution. Several workers have presented evi-
dence that folding of A/3 into a /3-sheet-containing structure
is intermolecular (Barrow et al., 1992) and that dimers are
formed (Hilbich et al., 1991; Sweeney et al., 1993). These
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FIGURE 9 Effect of residual solvent on aggregation rate. Samples were
prepared from 10 mg/ml stock solution in 0.1% TFA and diluted 20-fold
into PBSA, PBSA to which 5% (v/v) DMSO was added or PBSA to which
1.75% (v/v) ACN was added. (A) D, (solid symbols) and Ds (open sym-
bols) when stock solution was diluted into PBSA (@ or 0), PBSA plus
DMSO (A or A), or PBSA plus ACN (M or E). (B) (M)W when stock
solution was diluted into PBSA (0) or PBSA plus DMSO (@).
data can be explained by postulating that the first step in the
self-assembly of AP3 is formation of a (3-sheet dimer from
monomers. The equilibrium constant for this reaction de-
pends strongly on the solvent. Our work suggests that, in
PBSA, both the forward reaction (conversion of monomer
into (3-sheet dimer) and the reverse reaction (dissociation of
the dimer and loss of (3-sheet content) must be slow relative
to the rate of further association of the dimer into higher
order aggregates. Otherwise, the peptide structure in the
initial solvent would be irrelevant, and the monomer in
DMSO and the (3-sheet multimer in ACN/TFA would both
rapidly revert to the same starting point before continued
self-assembly, in contrast to what we observe.
Characterization of fibril dimensions in solution was car-
ried out with SLS by selecting appropriate particle structure
factors. For some samples, the wormlike chain model pro-
vided a good representation of P(q). The continuous worm-
like star model was chosen to represent light scattering data
where a bump in the Kratky plot showed that the wormlike
chain model was insufficient. This model requires that the
chain length of each arm is identical, which is clearly not
realistic. Still, it is the simplest model that includes both
branching and chain stiffness and is a useful, albeit some-
what artificial, construct that accomodates inclusion of the
concept of branching. The degree of branching is generally
quite low. We envision branching as an indication that
fibrils become partially entangled if the number density and
length becomes sufficiently large.
The apparent fibril diameter dapp' as calculated from the
mass linear density (M)W/LC, varied from 3.4 to 7.5 nm,
depending on the stock solvent. Fibrils of (3(1-38) and
13(1-40) were reported to have diameters of 7-9 nm from
electron microscopy studies (Fraser et al., 1991a). Direct
comparison of these values is uncertain because a solid
cylinder and tube with identical diameters on electron mi-
crographs would have considerably different mass linear
densities. Several possibilities must be considered to ex-
plain the variability in dapp with solvent. First, when starting
from different secondary structures and degrees of oli-
gomerization, it is possible that the self-assembly pathway
is affected. For example, it has been hypothesized that AP3
fibrils are cylindrical micelles with the hydrophobic termi-
nal regions of the peptides clustered at the center of the
fibril (Soreghan et al., 1994). If starting conditions affected
the number of peptide monomers incorporated into each
cross-sectional ring of the micelle, then the fibril diameter
would be altered. Or, the degree of lateral alignment of thin
filaments into fibrils could depend on the stock solvent.
Alternatively, dapp may reflect the weight fraction of peptide
in amyloid fibril form. Lc is indicative of fibril length only,
whereas (M)w is a weight-averaged molecular weight that
incorporates contributions from smaller molecular weight
species, if present, as well as fibrils. Under this assumption,
the weight fraction of peptide incorporated into fibrils in-
creases in the order 100% DMSO < 0.1% TFA < 10%
DMSO. This order is reasonably consistent with ThT fluo-
rescence data and with the degree of branching. An increas-
ing weight fraction of peptide in fibrillar form should lead to
an increased number and length of fibrils, which in turn
would cause an increase in fibril entanglement as detected
by increasing degrees of branching. The fact that dapp is
nearly constant with time argues against a significant role of
lateral alignment as a major reason for the variation in dapp
with stock solvent. dapp of fibrils in 10% DMSO stock
solution was very small (2.8 nm), yet electron micrographs
of these fibrils did not reveal any obvious differences in
fibril diameter from samples diluted into PBSA (not
shown). This observation, coupled with data showing that
monomers, dimers, and/or other small oligomers are de-
tected in amyloid fibril-containing solutions (Hilbich et al.,
1991; Shen et al., 1993; Snyder et al., 1994; Soreghan et al.,
1994), supports, but does not prove, the assignment of
differences in dapp to differences in weight fraction peptide
in fibrillar form.
If dapp scales with the weight fraction of peptide in
fibrillar form, then an increase in (M)W/Lc with time would
indicate that more nonfibrillar peptide was being converted
to fibrillar form. However, dapp (or (M)W/Lc) increased only
slightly with time. Under this assumption, then, the growth
in LC and (M)w for times greater than 12 h would be due
primarily to the continuing end-to-end association of shorter
fibrils into longer fibrils and, to a much lesser extent, to the
conversion of monomers or multimers into fibrils. Thus, the
increase in size that we observe over time would be asso-
ciated with an increase in fibril length but a decrease in
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fibril number density to maintain a nearly constant weight
fraction of peptide in fibril form. ThT results show only a
very slight increase in fluorescence intensity for the first
several days. This shows that fluorescence intensity is not
sensitive to changes in the average size of the fibrils but
may be related to the total fibril mass of the solution. The
increase in fluorescence intensity after several days oc-
curred on a time frame similar to the visual observation of
precipitates. If the peptide solution was agitated, both faster
formation of visible precipitates and a dramatic increase in
fluorescence intensity were observed (data not shown).
Thus, it is likely that ThT fluorescence intensity is also a
strong function of degree of solubilization.
For samples diluted from 0.1% TFA to different final
peptide concentrations, fibril length appeared to increase
with decreasing concentration. One possible explanation for
this phenomenon follows. The initial condition in the stock
solvent may be the primary determinant of the {3-sheet
content in the diluted sample, as described above. Thus,
decreasing the final peptide concentration would decrease
the absolute concentration of 13-sheet dimers but not the
fraction of peptide in the 13-sheet conformation. If formation
of a higher-order multimer by association of several 13-sheet
dimers is needed to initiate fibril formation, this process
would be highly concentration dependent because of the
high reaction order. Subsequent fibril elongation could re-
quire addition of dimers to the multimer or growing fibril or
end-to-end association of existing fibrils into longer fibrils,
both second-order processes. As the concentration de-
creased, fibril elongation would be increasingly favored
over fibril initiation. Furthermore, if fibril elongation pro-
cesses are diffusion limited, dimer addition would be faster
than end-to-end fibril-fibril association. The net effect
would be a decrease in the number of fibrils but an increase
in fibril length as peptide concentration decreased. This
mechanism could also explain the variability in fibril
growth rate for samples prepared from DMSO stock solu-
tions. dapp was identical for both rapidly and slowly growing
peptide from 100% DMSO stock solution, so, using the
arguments above, the weight fraction of peptide in fibrillar
form was also identical. The rapidly growing sample could
be one in which there are few, very long fibrils, and the
slowly growing sample could be one in which there are
more numerous, but shorter, fibrils. Stock solutions of
100% DMSO were the only ones that contained no 13-sheet
structure. Peptide assembly upon dilution into PBSA could
be highly sensitive to the balance between the rate of
conversion to 13-sheet-containing conformations (which
would be a more important step for samples diluted from
100% DMSO than for other samples) and the rate of fibril
initiation from the hypothesized 13-sheet dimers. No fibrils
would form until a sufficient concentration of 13-sheet
dimers built up. Once this happened, new dimers could be
incorporated into the growing fibril or could self-assemble
to initiate additional fibrils. Which is more likely to happen
depends in a highly nonlinear way on the rate of production
and the rate of addition of dimers to the growing fibril.
Small differences in initial conditions could potentially lead
to large differences in the final fibril length.
When diluted from ACN/TFA, the peptide aggregated
quickly into extremely long fibrils. In ACN/TFA, the pep-
tide retained the same 13-sheet content as a solution of fibrils
at physiological pH. This solvent is likely to disrupt hydro-
phobically and electrostatically driven association, which
could therefore prevent extensive self-assembly of 13-sheet
conformers into the hypothesized multimers for fibril initi-
ation. It is possible that more extensive hydrogen-bonded
single 13-sheets are present in this solvent than in any of the
other stock solutions. In contrast, a significant fraction of
the peptide was present as relatively short, amyloid fibrils
in 10% DMSO, but these fibrils did not increase in length
upon dilution into PBSA as quickly as the fibrils from the
ACN/TFA solution. The difference between the two sam-
ples could be explained by postulating that the difference in
starting condition leads to fewer, longer fibrils in the case
of ACN/TFA stock solvent and more numerous, shorter
fibrils for the 10% DMSO stock solvent, possibly resulting
from the competition between fibril initiation versus fibril
elongation.
It is interesting to note that D 1 for 13(1-28) in PBSA,
when predissolved in 0.1% TFA, is significantly greater
than for 1(1-39) (Shen et al., 1993). Thus, fibrils formed
from 13(1-28) are significantly longer than 13(1-39) fibrils,
but 13(1-28) has a larger fraction of peptide in nonfibrillar
form and is less neurotoxic (Yankner et al., 1990). This
suggests that perhaps self-assembly of 13(1-28) is limited by
fibril initiation, not by fibril elongation, to a greater extent
than 1(1-39).
We thus envision a model of self-assembly of A13 that
incorporates the following steps: (1) conversion of mono-
mer to 13-sheet peptide, possibly dimeric and possibly cor-
responding to the 13-crystallites detected by x-ray diffraction
(Inouye et al., 1993); (2) fibril initiation by association of
dimers into multimers, perhaps similar to the pentameric or
hexameric structures seen on cross section in some micro-
graphs (Fraser et al., 1991b); (3) fibril growth by addition of
13-sheet dimer to fibrils; (4) continued fibril elongation by
end-to-end association of shorter fibrils; (5) entanglement or
loose association of fibrils into clusters; and (6) precipita-
tion when fibrils get sufficiently long and sufficiently nu-
merous. From analysis of our data, we propose that the rate
of dissociation of the hypothesized 13-sheet dimer to the
non-13-sheet monomer is slow relative to the rate of fibril
initiation by self-assembly of dimers into higher order mul-
timers. We further postulate that fibril initiation is slower
and has a higher reaction order than fibril growth by addi-
tion of dimer. Any multimeric (fibril initiator) species that
formed slowly but reacted rapidly would be present in
virtually undetectable concentration. This model could ac-
count for the observation that addition (seeding) of pre-
formed fibrils induces peptide aggregation (Jarrett et al.,
1993; Snyder et al., 1994). The number, density, and length
of dimers, the rate of association of dimers into multimers,
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of fibrils depends on the balance between initial B-sheet
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peptide content and rates of conversion of monomer to
(3-sheet dimer, fibril initiation, and fibril elongation. It is
unlikely that a simple characterization of aggregation such
as ThT fluorescence or centrifugation suffices to describe
the complex peptide self-assembly process, to evaluate the
role of self-assembly in neurotoxicity, or to determine the
efficacy of potential inhibitors of AJ3 assembly.
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